ASO Visual Abstract: Impact of Age on Use of Neoadjuvant Chemoimmunotherapy and Outcomes for Patients with Triple-Negative Breast Cancer.

Schrank Z; Landrum K; Agala CB; Gallagher K; Ollila D; Spanheimer PM; Selfridge JM

doi:10.1245/s10434-026-19334-5

← 뒤로

ASO Visual Abstract: Impact of Age on Use of Neoadjuvant Chemoimmunotherapy and Outcomes for Patients with Triple-Negative Breast Cancer.

0/5 보강

Annals of surgical oncology 📖 저널 OA 24.4% 2021~2026 2026

Schrank Z, Landrum K, Agala CB, Gallagher K, Ollila D, Spanheimer PM

PubMed ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

↓ .bib ↓ .ris

APA Schrank Z, Landrum K, et al. (2026). ASO Visual Abstract: Impact of Age on Use of Neoadjuvant Chemoimmunotherapy and Outcomes for Patients with Triple-Negative Breast Cancer.. Annals of surgical oncology. https://doi.org/10.1245/s10434-026-19334-5

MLA Schrank Z, et al.. "ASO Visual Abstract: Impact of Age on Use of Neoadjuvant Chemoimmunotherapy and Outcomes for Patients with Triple-Negative Breast Cancer.." Annals of surgical oncology, 2026.

PMID 41764128 ↗

DOI 10.1245/s10434-026-19334-5

같은 제1저자의 인용 많은 논문 (2)

ASO Author Reflections: Do Older Triple-Negative Breast Cancer Patients Respond Differently to Neoadjuvant Chemoimmunotherapy?
Annals of surgical oncology 2026
Impact of Age on Use of Neoadjuvant Chemoimmunotherapy and Outcomes for Patients with Triple-Negative Breast Cancer.
Annals of surgical oncology 2026